Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone

Description

Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone are characterised by the pattern and consequences of use of these substances. There is a wide array of naturally occurring and synthetically produced psychostimulants other than cocaine. The most numerous of this group are the amphetamine-type substances, including methamphetamine. Prescribed stimulants including dexamphetamine are indicated for a limited number of conditions such as for Attention Deficit Hyperactivity Disorder. Methcathinone, known in many countries as ephedrone, is a synthetic potent stimulant that is a structural analogue of methamphetamine and is related to cathinone. All these drugs have primarily psychostimulant properties and are also vasoconstrictors to a varying degree. They induce euphoria and hyperactivity as may be seen in Stimulant Intoxication. They have potent dependence-producing properties, which may lead to the diagnosis of Stimulant Dependence and Stimulant Withdrawal following the cessation of use. Several Stimulant-Induced Mental Disorders are described.

Excludes

6C45 – Disorders due to use of cocaine
6C47 – Disorders due to use of synthetic cathinones
6C48 – Disorders due to use of caffeine
QE11.4 – Hazardous use of stimulants including amphetamines or methamphetamine

Exclusions from above levels

QE62 – Uncomplicated bereavement
QE84 – Acute stress reaction

Child codes

6C46.0 – Episode of harmful use of stimulants including amphetamines, methamphetamine or methcathinone
6C46.1 – Harmful pattern of use of stimulants including amphetamines, methamphetamine or methcathinone
6C46.2 – Stimulant dependence including amphetamines, methamphetamine or methcathinone
6C46.3 – Stimulant intoxication including amphetamines, methamphetamine or methcathinone
6C46.4 – Stimulant withdrawal including amphetamines, methamphetamine or methcathinone
6C46.5 – Stimulant-induced delirium including amphetamines, methamphetamine or methcathinone
6C46.6 – Stimulant-induced psychotic disorder including amphetamines, methamphetamine or methcathinone
6C46.7 – Certain specified stimulant-induced mental or behavioural disorders including amphetamines, methamphetamine or methcathinone
6C46.Y – Other specified disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone
6C46.Z – Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone, unspecified

Sibling codes

6C40 – Disorders due to use of alcohol
6C41 – Disorders due to use of cannabis
6C42 – Disorders due to use of synthetic cannabinoids
6C43 – Disorders due to use of opioids
6C44 – Disorders due to use of sedatives, hypnotics or anxiolytics
6C45 – Disorders due to use of cocaine
6C47 – Disorders due to use of synthetic cathinones
6C48 – Disorders due to use of caffeine
6C49 – Disorders due to use of hallucinogens
6C4A – Disorders due to use of nicotine
6C4B – Disorders due to use of volatile inhalants
6C4C – Disorders due to use of methylene-dioxymethamphetamine [MDMA] or related drugs, including methylene-dioxyamphetamine [MDA]
6C4D – Disorders due to use of dissociative drugs including ketamine or phencyclidine (PCP)
6C4E – Disorders due to use of other specified psychoactive substances, including medications
6C4F – Disorders due to use of multiple specified psychoactive substances, including medications
6C4G – Disorders due to use of unknown or unspecified psychoactive substances
6C4H – Disorders due to use of non-psychoactive substances
6C4Y – Other specified disorders due to substance use
6C4Z – Disorders due to substance use, unspecified

Foundation entity

Disorders due to use of stimulants including amphetamines, methamphetamine or methcathinone – http://id.who.int/icd/entity/1016273204

Allowed postcoordination axes

Part of: 06: Mental, behavioural or neurodevelopmental disorders